Capivasertib
id:
capivasertib-187-15762661
title:
Capivasertib
text:
Capivasertib, sold under the brand name Truqap, is an anti-cancer medication used for the treatment of breast cancer. It is taken by mouth. The most common adverse reactions include diarrhea, cutaneous adverse reactions, increased random glucose, decreased lymphocytes, decreased hemoglobin, increased fasting glucose, nausea, fatigue, decreased leukocytes, increased triglycerides, decreased neutrophils, increased creatinine, vomiting, and stomatitis. In November 2023, capivasertib was approved in
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Capivasertib
date created:
2023-11-16T23:57:50Z
date modified:
2024-09-08T15:37:53Z
main entity:
{"identifier":"Q27074756","url":"https://www.wikidata.org/entity/Q27074756"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c1/Capivasertib.svg","width":512,"height":230}
fields total:
13
integrity:
16